Governance Framework of Altura Cancer Research

Mission and Purpose

Altura Cancer Research exists to help advance cancer research by unifying publicly available cancer knowledge into a queryable system and using advanced computational methods, including artificial intelligence, to surface overlooked connections, generate testable hypotheses, and support research progress.

As a for-profit company, we believe disciplined execution, long-term incentives, and strong talent alignment can help accelerate meaningful scientific work. At the same time, we recognize that cancer research carries special ethical and societal responsibilities. Our governance is intended to help ensure that commercial activity supports, rather than undermines, our broader mission.

Governance Principles

Our governance framework is guided by the following principles:

Board Oversight

The Board of Directors is responsible for the overall oversight of Altura Cancer Research. The board’s role includes oversight of:

• company strategy
• major financing and capital allocation decisions
• risk management
• executive leadership
• governance standards
• major partnerships and strategic transactions
• mission alignment at the institutional level

The board is expected to exercise independent judgment in the best interests of the company and to help ensure that the company is governed responsibly and sustainably.

Management Responsibility

Day-to-day management of the company is delegated to executive leadership, subject to board oversight. Management is responsible for implementing company strategy, managing operations and personnel, establishing internal controls and reporting systems, maintaining appropriate records, and supporting lawful and compliant conduct.

Scientific and Research Integrity

Altura Cancer Research is committed to conducting and communicating research-related work responsibly. This includes:

• grounding research outputs in credible evidence and documented sources
• distinguishing clearly between hypotheses, computational inferences, and validated conclusions
• using appropriate expert review for high-stakes scientific interpretations
• avoiding exaggerated claims about clinical utility, efficacy, or certainty
• supporting reproducibility, provenance, and traceability where practical

Data Governance and Privacy

We aim to manage data in a manner that is lawful, secure, and appropriate. Depending on the type of work performed, our practices include access controls, data minimization, de-identification or anonymization, and contractual controls with data providers. Where we use health-related data, we intend to do so only under appropriate legal and ethical frameworks.

Use of Artificial Intelligence and Computational Systems

We seek to use AI tools in ways that are scientifically responsible, proportionate to the stakes involved, and subject to human judgment where appropriate. AI-generated or computational outputs should not be treated as clinical advice or validated scientific conclusions without appropriate review and context.

Conflicts of Interest

Directors, officers, employees, advisors, and relevant contractors are expected to avoid improper conflicts of interest. A conflict of interest may include any financial, personal, or advisory relationship that could reasonably be expected to interfere with objective judgment or loyalty to the company.

Compliance and Risk Management

We aim to maintain reasonable policies and oversight processes to identify and manage risk in areas such as corporate compliance, privacy, data security, research integrity, and regulatory exposure. Risks should be considered thoughtfully and escalated appropriately.

Public Communications and Transparency

Public statements and messaging should seek to avoid misleading claims, distinguish present capabilities from future goals, and communicate uncertainty where relevant. We choose to publish findings while also preserving proprietary rights where doing so supports long-term mission execution.

Intellectual Property and Mission Balance

As a for-profit company, Altura Cancer Research may develop and protect proprietary tools and datasets. We believe mission and proprietary protection can coexist. Decisions regarding open-sourcing versus proprietary retention will be made with attention to company viability and research value.

Advisors and External Experts

The company may engage scientific advisors, legal counsel, technical experts, or clinicians to support decision-making. Advisors provide input, but advisory roles do not replace management responsibility or board oversight unless formally designated otherwise.

Ethical Positioning

Altura Cancer Research is not a hospital, physician practice, or treatment provider. The company’s work is intended to support research and scientific reasoning. We seek to operate with humility, rigor, and respect for the real-world consequences of scientific work.

Review and Amendment

This governance framework may be updated from time to time as the company evolves and its operations expand. Amendments may be made by the company in accordance with its applicable corporate authority structure.

Contact

Questions regarding governance, research standards, partnerships, or institutional practices may be directed to: